메뉴 건너뛰기




Volumn 55, Issue 7, 1999, Pages 521-525

Absorption, metabolism and excretion of a single oral dose of 14C- repaglinide during repaglinide multiple dosing

Author keywords

Insulin secretagogue; Repaglinide; Type 2 diabetes

Indexed keywords

CARBON 14; REPAGLINIDE;

EID: 0032830946     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050667     Document Type: Article
Times cited : (69)

References (7)
  • 1
    • 0030596338 scopus 로고    scopus 로고
    • Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta cell to compensate for insulin resistance
    • Polonsky KS, Sturis J, Bell GI (1996) Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334: 777-783
    • (1996) N Engl J Med , vol.334 , pp. 777-783
    • Polonsky, K.S.1    Sturis, J.2    Bell, G.I.3
  • 2
    • 0030059853 scopus 로고    scopus 로고
    • The pathogenesis of type II diabetes mellitus. A polygenic disease
    • Sacks DB, McDonald JM (1996) The pathogenesis of type II diabetes mellitus. A polygenic disease. Am J Clin Pathol 105: 149-156
    • (1996) Am J Clin Pathol , vol.105 , pp. 149-156
    • Sacks, D.B.1    McDonald, J.M.2
  • 3
    • 0031892659 scopus 로고    scopus 로고
    • Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes
    • Fuhlendorff J, Rorsman P, Kofod H, Brand CL, Rolin B, MacKay P, Shymko R, Carr RD (1998) Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47: 345-351
    • (1998) Diabetes , vol.47 , pp. 345-351
    • Fuhlendorff, J.1    Rorsman, P.2    Kofod, H.3    Brand, C.L.4    Rolin, B.5    MacKay, P.6    Shymko, R.7    Carr, R.D.8
  • 4
    • 0029817751 scopus 로고    scopus 로고
    • Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166
    • Kikuchi M (1996) Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166. Diabet Med 13: S151-S155
    • (1996) Diabet Med , vol.13
    • Kikuchi, M.1
  • 6
    • 0025010886 scopus 로고
    • Good clinical practice for trials on medicinal products in the European Community. Brussels 1990, document III/3976/88/EN, final approved by CPMP 11.07.1990
    • Commission of the European Communities, CPMP working party on efficacy of medical products (1990) Good clinical practice for trials on medicinal products in the European Community. Brussels 1990, document III/3976/88/EN, final approved by CPMP 11.07.1990. Pharmacol Toxicol 67: 361-372
    • (1990) Pharmacol Toxicol , vol.67 , pp. 361-372
  • 7
    • 0031593457 scopus 로고    scopus 로고
    • Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers
    • Hatorp V, Oliver S, Su C-APF (1998) Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers. Int J Clin Pharmacol Ther 36: 636-641
    • (1998) Int J Clin Pharmacol Ther , vol.36 , pp. 636-641
    • Hatorp, V.1    Oliver, S.2    Su, C.-A.P.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.